Metabolic dysfunction-associated steatohepatitis (MASH): Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
ClaireLewis (talk | contribs) |
||
| Line 23: | Line 23: | ||
==Disposition== | ==Disposition== | ||
*Discharge unless complications | |||
==See Also== | ==See Also== | ||
Revision as of 23:14, 29 September 2019
Background
- Fatty liver disease due to causes other than excessive alcohol
- Associated with insulin resistance and metabolic syndrome
Clinical Features
- Often asymptomatic or with mild RUQ discomfort
- Signs of portal hypertension (e.g. ascites) if advanced fibrosis
- Hepatomegaly
Differential Diagnosis
- Cirrhosis
- Hepatitis
- Budd-Chiari syndrome
- Hepatocellular carcinoma
- CHF (right heart failure]]
Evaluation
Management
- Treat complications of portal hypertension, if present
Disposition
- Discharge unless complications